siRNA, Anti-XPO7, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT36644WQ-2OMe)

The product SIRGT36644WQ-2OMe is a type of small interfering RNA (siRNA) that targets XPO7 gene and regulates the expression of gene. The siRNA interferes with the expression of XPO7 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_015024.4
Alternative Names EXP7; RANBP16
Related Diseases Hemolytic Anemia and Arts Syndrome
Purification HPLC
Target Gene
Gene ID 23039
Uniprot ID Q9UIA9
Sub Cat Target Species Modification Scale  
SIRGT37644WQ-2F XPO7 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT38644WQ-2MOE XPO7 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT39644WQ-LNA XPO7 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT36644WQ-RB XPO7 Human Ribo-modified Inquiry
SIRGT37644WQ-BB XPO7 Human Backbone-modified Inquiry

Related Products